<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cayman Journal - Soleno Therapeutics Inc (SLNO)</title>
    <description>Latest news, press releases, and SEC filings for Soleno Therapeutics Inc (SLNO)</description>
    <link>https://caymanjournal.com/stock/SLNO</link>
    <language>en-us</language>
    
    <copyright>Copyright 2026, Cayman Journal</copyright>
    <managingEditor>editorial@caymanjournal.com (Editorial Team)</managingEditor>
    <webMaster>webmaster@caymanjournal.com (Web Master)</webMaster>
    <lastBuildDate>Mon, 27 Apr 2026 22:45:55 GMT</lastBuildDate>
    <ttl>60</ttl>
    <atom:link href="https://caymanjournal.com/stock/SLNO/feed.xml" rel="self" type="application/rss+xml" />
    <image>
      <url>https://caymanjournal.com/logo.png</url>
      <title>Cayman Journal</title>
      <link>https://caymanjournal.com</link>
      <width>144</width>
      <height>144</height>
    </image>

    <item>
      <title>SC 14D9 — SOLENO THERAPEUTICS INC</title>
      <description># 📝 What This Document Is 📄

This document is an SEC filing called a Schedule 14D-9. Think of it as a comprehensive, legally required informational packet provided to stockholders when a major corporate event, like a merger or acquisition, is proposed. 🚨 Since a deal was being discussed, the Sole</description>
      <link>https://caymanjournal.com/stock/SLNO/sec-filing/0001193125-26-162853</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/SLNO/sec-filing/0001193125-26-162853</guid>
      <pubDate>Mon, 20 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item><item>
      <title>SC TO-T — SOLENO THERAPEUTICS INC</title>
      <description># 📰 What This Document Is 📃

This document is a highly formal **Offer to Purchase** (an SEC filing, Form SC TO-T). Essentially, it is a formal, legally detailed proposal from one company to another. 👉 It means that Neurocrine Biosciences, Inc., is offering to buy out every single share of Soleno </description>
      <link>https://caymanjournal.com/stock/SLNO/sec-filing/0001193125-26-162715</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/SLNO/sec-filing/0001193125-26-162715</guid>
      <pubDate>Mon, 20 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item><item>
      <title>SC TO-C — SOLENO THERAPEUTICS INC</title>
      <description># 🧾 What This Document Is
This is a transcript of a **corrected investor conference call** from April 6, 2026. Neurocrine Biosciences (NBIX) is explaining its plan to acquire Soleno Therapeutics (SLNO). This call followed the official announcement and is part of the SEC filing process for a tender </description>
      <link>https://caymanjournal.com/stock/SLNO/sec-filing/0001193125-26-144170</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/SLNO/sec-filing/0001193125-26-144170</guid>
      <pubDate>Tue, 07 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item><item>
      <title>SC TO-C — SOLENO THERAPEUTICS INC</title>
      <description># 🧾 What This Document Is
This is a series of announcements filed with the SEC (form SC TO-C) about a **planned acquisition**. Neurocrine Biosciences (NBIX) is telling the world it plans to buy all of Soleno Therapeutics (SLNO) shares through a process called a **tender offer**. It&apos;s not the final </description>
      <link>https://caymanjournal.com/stock/SLNO/sec-filing/0001193125-26-143988</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/SLNO/sec-filing/0001193125-26-143988</guid>
      <pubDate>Mon, 06 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item>
  </channel>
</rss>